• Icariin–PDE5A Control of Spermatogonial Stem Cells

  2026-08-16

  This study identifies PDE5A as a molecular target through which icariin promotes mouse spermatogonial stem cell viability and DNA synthesis while limiting hydrogen peroxide-associated DNA damage. Its combination of cell-based assays, SPRi, molecular docking, and in vivo reproductive assessment provides a mechanistic framework for evaluating icariin in male reproductive biology.

• BML-277 for Chk2 DNA Damage Studies

  2026-08-15

  BML-277 provides a nanomolar, ATP-competitive route to interrogate Chk2 in biochemical assays, T-cell radioprotection models, and DNA damage signaling. This workflow-oriented guide connects Chk2 perturbation with the nuclear cGAS–TRIM41–ORF2p axis while separating established evidence from practical assay recommendations.

• MCL-1 Dependence in Breast Cancer: What the Study Shows

  2026-08-14

  Campbell and colleagues show that established breast tumors depend on MCL-1 primarily because of its canonical anti-apoptotic control of BAX/BAK, rather than because of an exclusively non-apoptotic function. Genetic deletion and pharmacological inhibition both impaired tumor growth, while removal of BAX and BAK prevented these effects, providing a mechanistic framework for interpreting MCL-1 inhibitor studies in breast cancer.

• 5-Methyl-CTP for Reliable mRNA Assays

  2026-08-14

  A scenario-based guide to using 5-Methyl-CTP (SKU B7967) in modified mRNA synthesis workflows that support cell viability, proliferation, and cytotoxicity studies. It covers experimental controls, stock handling, interpretation, and practical supplier-selection criteria.

• EZ Cap™ Human PTEN mRNA: Workflow Guide

  2026-08-13

  Build reproducible PTEN-restoration assays with a Cap 1, polyadenylated mRNA designed for transient protein expression. This guide connects routine mRNA transfection and expression experiments with emerging hyaluronate-lipid nanoparticle strategies for localized cancer research and gene therapy research.

• Nuclear cGAS, CHK2, and L1 Retrotransposition

  2026-08-13

  The reference study identifies a nuclear DNA-damage pathway in which CHK2-phosphorylated cGAS promotes TRIM41-dependent ubiquitination and degradation of the LINE-1 protein ORF2p. This mechanism links checkpoint signaling to suppression of retrotransposition, with implications for genome integrity, cellular senescence, aging, and cancer research.

• Fangchinoline, TFEB, and H1N1 Infection

  2026-08-12

  The reference study identifies fangchinoline as a lysosome-targeted host-directed antiviral that restores TFEB-dependent lysosomal gene expression and restricts H1N1 infection. Its most important mechanistic insight is that lysosomal alkalinization, altered autophagic flux, and impaired endolysosomal trafficking converge to inhibit viral entry rather than merely suppressing later replication.

• Notch1–YY1–ICAM1 Axis in HCC Immunotherapy

  2026-08-12

  The reference study identifies the Notch1–YY1–ICAM1 pathway as a mechanistic determinant of immunotherapy response in hepatocellular carcinoma. Its findings suggest that suppressing YY1 can restore ICAM1-dependent CD8+ T-cell cytotoxicity and improve PD-L1 blockade without the broader toxicity concerns associated with direct Notch1 inhibition.

• Dicloxacillin Activity Against Intracellular S. aureus

  2026-08-11

  The reference study combined THP-1 cell assays with a murine peritonitis model to compare dicloxacillin activity against intracellular and extracellular Staphylococcus aureus. Its central practical finding was that free-drug exposure above the MIC, expressed as fT>MIC, best predicted efficacy in both bacterial compartments, while sampling time strongly influenced extracellular results.

• GluN2A/2B Control Trigeminal Allodynia in TMJ Inflammation

  2026-08-11

  This study identifies distinct roles for GluN2A and GluN2B in linking trigeminal ganglion sensitization with connexin and pannexin signaling during temporomandibular joint inflammation. Its combination of conditional knockout, behavioral testing, satellite glial cell experiments, and pathway analysis clarifies how NMDAR-dependent cell coupling may contribute to orofacial inflammatory allodynia.

• Regorafenib: From Kinase Breadth to Melanoma Biology

  2026-08-10

  Regorafenib (BAY 73-4506) is more than a broad-spectrum kinase tool: emerging melanoma data connect its anti-invasive activity to RRM2 suppression and ERK/E2F3 signaling. This thought-leadership guide translates that mechanism into practical strategies for angiogenesis research, cancer biology research, and translational model development.

• Multianimal MRI for Pancreatic Tumor Monitoring

  2026-08-09

  Kempinska and colleagues describe a four-chamber MRI workflow that enables high-resolution imaging of up to four KPC mice in one acquisition, improving the efficiency of pancreatic tumor detection and longitudinal measurement. The protocol was also used as a proof-of-concept framework for evaluating gemcitabine treatment response, linking reproducible imaging endpoints with preclinical therapeutic studies.

• WIP1/PPM1D, p38 MAPK, and AKI Pyroptosis

  2026-08-08

  The reference study identifies WIP1/PPM1D as a negative regulator of p38 MAPK-dependent renal tubular pyroptosis during sepsis-associated acute kidney injury. By combining injury models, single-cell sequencing, patient tissue analysis, and pharmacological inhibition, it shows that CCT007093 intensifies inflammatory cell death through p38 MAPK activation, providing a mechanistic framework for studying the PPM1D signaling pathway in kidney injury.

• A-1210477: MCL-1 Inhibitor Workflow Guide

  2026-08-07

  A-1210477 provides a selective in vitro route to test whether cancer cells rely on MCL-1-mediated survival rather than merely showing nonspecific cytotoxicity. This practical guide connects stock preparation, dose-response design, mitochondrial apoptosis assays, combination testing, and troubleshooting for more reproducible cancer research.

• Silymarin & Silybin A: Optimized Workflows for Liver Researc

  2026-08-07

  Silybin A, the bioactive powerhouse within Silymarin, unlocks reproducible, high-fidelity models of hepatoprotection and metabolic enzyme modulation. This guide translates cutting-edge chemistry and best practices into actionable protocols, troubleshooting insights, and comparative advantages for bench researchers. Learn how APExBIO's Silybin A reshapes liver disease and oxidative stress workflows.

15288 records 1/1020 page Next 12345 下5页 Last page